Chemed Corporation $CHE Shares Sold by State of Alaska Department of Revenue

Key Points

• State of Alaska Department of Revenue trimmed its Chemed stake by 92.9% in Q4, selling 18,298 shares and leaving 1,406 shares valued at about $601,000.
• Chemed raised FY2026 guidance to $24.00–$24.75, beat Q1 adjusted EPS ($5.65 vs. ~$5.39), and repurchased 500,000 shares while buying two Roto‑Rooter franchises, supporting a constructive outlook.
• CEO Kevin McNamara sold 2,000 shares for roughly $806,360 (a 2.09% reduction) and insiders own ~3.29% overall, while Roto‑Rooter margin pressure and GAAP EPS lagging adjusted results are potential investor concerns.

State of Alaska Department of Revenue trimmed its holdings in shares of Chemed Corporation (NYSE:CHE - Free Report) by 92.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,406 shares of the company's stock after selling 18,298 shares during the quarter. State of Alaska Department of Revenue's holdings in Chemed were worth $601,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. WCM Investment Management LLC grew its stake in Chemed by 3.8% during the 3rd quarter. WCM Investment Management LLC now owns 661 shares of the company's stock valued at $299,000 after purchasing an additional 24 shares in the last quarter. Eukles Asset Management raised its position in shares of Chemed by 0.4% in the 3rd quarter. Eukles Asset Management now owns 6,031 shares of the company's stock valued at $2,700,000 after purchasing an additional 24 shares in the last quarter. Cim LLC raised its position in shares of Chemed by 1.1% in the 3rd quarter. Cim LLC now owns 2,139 shares of the company's stock valued at $958,000 after purchasing an additional 24 shares in the last quarter. Smartleaf Asset Management LLC boosted its stake in shares of Chemed by 71.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company's stock valued at $27,000 after buying an additional 25 shares during the last quarter. Finally, HM Payson & Co. boosted its stake in shares of Chemed by 35.5% during the 3rd quarter. HM Payson & Co. now owns 103 shares of the company's stock valued at $46,000 after buying an additional 27 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction that occurred on Thursday, March 12th. The stock was sold at an average price of $403.18, for a total value of $806,360.00. Following the sale, the chief executive officer directly owned 93,719 shares in the company, valued at $37,785,626.42. This trade represents a 2.09% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 3.29% of the stock is owned by company insiders.

Chemed News Summary

Here are the key news stories impacting Chemed this week:

• Positive Sentiment: Raised full‑year guidance — Chemed updated FY2026 EPS guidance to $24.00–$24.75, above Street consensus (~$23.48), signaling stronger-than-expected outlook driven by VITAS. GlobeNewswire: Q1 Results
• Positive Sentiment: Adjusted EPS beat — Chemed reported adjusted EPS of $5.65 vs. consensus ~$5.39, topping estimates and supporting the rally. Zacks: CHE Beats Q1
• Positive Sentiment: Buyback and small M&A — Company repurchased 500,000 shares in Q1 and acquired two Roto‑Rooter franchises for $20.6M, both shareholder-friendly moves that reduce share count and expand core footprint. GlobeNewswire: Q1 Results
• Positive Sentiment: Analyst support and targets remain constructive — Wall Street sentiment and recent price targets (median ~$475; some higher) provide additional backing for the stock post‑print. QuiverQuant: Analyst & Price Target Summary
• Neutral Sentiment: VITAS drove growth — Hospice unit (VITAS) showed modest revenue and census growth (net patient revenue +3.1%, ADC +2.2%, admissions +6.9%), supporting the company’s guidance raise but with limited margin expansion. GlobeNewswire: VITAS Results
• Neutral Sentiment: Operating cash flow strength — Operating cash flow improved materially year‑over‑year, improving financial flexibility even as capex rose to support operations. QuiverQuant: Cash Flow Details
• Negative Sentiment: Roto‑Rooter margin pressure — The plumbing segment saw revenue tick down ~0.9% and adjusted EBITDA decline ~9.6% with a ~218‑bp margin drop, a near‑term headwind to consolidated margins. GlobeNewswire: Roto‑Rooter Results
• Negative Sentiment: GAAP EPS vs. adjusted — GAAP diluted EPS ($4.84) lags adjusted EPS, and some metrics (net income, operating profit) declined year‑over‑year, which could temper enthusiasm if investors focus on GAAP trends. GlobeNewswire: GAAP vs Adjusted
• Negative Sentiment: Insider selling noted — Recent insider sales (including CEO) were reported in the quarter, which some investors track as a cautionary signal. QuiverQuant: Insider Activity

Chemed Price Performance

Shares of NYSE CHE opened at $383.42 on Friday. The firm has a market capitalization of $5.60 billion, a PE ratio of 20.87, a P/E/G ratio of 1.48 and a beta of 0.49. Chemed Corporation has a 1-year low of $365.20 and a 1-year high of $583.96. The business's fifty day moving average price is $404.22 and its two-hundred day moving average price is $426.40.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, topping the consensus estimate of $5.30 by $0.35. The business had revenue of $657.51 million during the quarter, compared to analyst estimates of $659.22 million. Chemed had a net margin of 10.48% and a return on equity of 25.66%. The company's quarterly revenue was up 1.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Equities research analysts expect that Chemed Corporation will post 21.92 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were given a dividend of $0.60 per share. The ex-dividend date was Monday, February 23rd. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. Chemed's payout ratio is currently 13.06%.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on CHE. Zacks Research cut shares of Chemed from a "hold" rating to a "strong sell" rating in a report on Wednesday, March 4th. Oppenheimer cut their target price on shares of Chemed from $580.00 to $500.00 and set an "outperform" rating on the stock in a research note on Friday, February 27th. Jefferies Financial Group cut shares of Chemed from a "buy" rating to a "hold" rating in a research report on Thursday, January 22nd. Weiss Ratings lowered Chemed from a "hold (c-)" rating to a "sell (d+)" rating in a report on Monday, April 13th. Finally, Royal Bank Of Canada reaffirmed a "sector perform" rating and set a $422.00 target price (down from $572.00) on shares of Chemed in a report on Friday, February 27th. Two investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $498.00.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.